Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD

• Status: Not yet recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To determine the efficacy of deutetrabenazine to control symptoms of dysphagia associated with HD.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundacion Huntington Puerto Rico
• Treatments: Tetrabenazine

Criteria

Inclusion Criteria:

• Confirmed diagnosis of HD

• Symptoms of dysphagia

• Must be able to swallow tablets

Exclusion Criteria:

• Other confounding diseases that affect swallowing

• Depression

• Hepatic impairment

• Renal impairment

• Dementia